Researchers at Rutgers Cancer Institute explored informing patients of their potentially increased risk for genetically-inherited cancers and navigating them to receive genetic counseling and/or testing through phone-based decision coaching and navigation. The project, called the Genetic Risk Assessment for Cancer Education and Empowerment (GRACE), was led by Anita Kinney, PhD, director of the Cancer Health Equity Center of Excellence at Rutgers Cancer Institute and Rutgers School of Public Health, and associate director for Population Science and Community Outreach at Rutgers Cancer Institute. Read more

In recent years, colorectal cancer diagnoses and deaths among individuals younger than 50 years of age have increased. Researchers are actively working to better understand the factors associated with this rise in incidence. Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and associate director for Clinical Research at Rutgers Cancer Institute of New Jersey; and director of Oncology Research, RWJBarnabas Health, shares more about the latest data, the factors driving the rise in colorectal cancer for young people and what individuals should know about the disease. Read more

This year’s social work month theme designated by the National Association of Social Workers is “social work breaks barriers,” which highlights how social workers, including those at Rutgers Cancer Institute, overcome hurdles to improve the lives of others. Learn about our oncology social work program, which is home to compassionate and caring professionals with unique specialties that help patients and their families effectively cope with the logistical and emotional challenges of cancer. Read more

When 3-year old Jimmy was diagnosed with acute lymphocytic leukemia (ALL) in April 2021, his parents, James and Lisa Tansey, knew their son needed the best most advanced care which was available at Rutgers Cancer Institute of New Jersey and Monmouth Medical Center, an RWJBarnabas Health facility. Learn about Jimmy’s story and the exceptional care he’s receiving including participating in a clinical trial. Read more

According to the American Cancer Society, there will be an estimated 82,290 new cases of bladder cancer in the U.S. in 2023. To diagnose this disease, physicians inspect the inside of the bladder using a long, thin tube with a video camera on the end called a cystoscope. The Urologic Oncology Program at Rutgers Cancer Institute and Robert Wood Johnson University Hospital offers blue light cystoscopy with Cysview®, which allows physicians to see smaller tumors and lesions that may not have been visible with previous standard technology. Learn more about this procedure, the benefits and who is eligible.